Table 4.
Metabolic syndrome and criteria prevalence.
| FE | <10 yr | 10 to 20 yr | >20 yr | p | |
|---|---|---|---|---|---|
| MS ATP-III | 17% (17) | 21.5% (28) | 34.9% (37) | 36.7% (29) | 0.0026 |
| Criteria: | |||||
| Waist (M>102, F>88) | 18% (18) | 32.3% (42) | 45.3% (48) | 44.3% (42) | 0.0001 |
| BP (≥ 130/85) | 43% (43) | 34.6% (45) | 57.5% (61) | 64.7% (51) | 0.0001 |
| HDL (M<40 mg/dl, F<50 mg/dl) | 26% (26) | 27.7% (36) | 31.1% (33) | 31.6% (26) | ns |
| TG (≥ 150 mg/dl) | 33% (33) | 36.1% (47) | 50.9% (54) | 46.8% (37) | 0.0252 |
| Glucose (≥ 110 mg/dl) | 3% (3) | 2.3% (3) | 11.3% (12) | 20.2% (16) | 0.0001 |
| MS ATP-III A (AHA) | 18% (18) | 24.6% (32) | 39.6% (42) | 44.3% (35) | 0.0001 |
| Criteria: | |||||
| Waist (M>102, F>88) | 18% (18) | 32.3% (42) | 45.3% (48) | 44.3% (42) | 0.0001 |
| BP (≥ 130/85) | 43% (43) | 34.6% (45) | 57.5% (61) | 64.7% (51) | 0.0001 |
| HDL (M<40 mg/dl, F<50 mg/dl) | 26% (26) | 27.7% (36) | 31.1% (33) | 31.6% (26) | ns |
| TG (≥ 150 mg/dl) | 33% (33) | 36.1% (47) | 50.9% (54) | 46.8% (37) | 0.0252 |
| Glucose(≥ 100 mg/dl) | 8% (8) | 16.9% (22) | 27.4% (29) | 40.5% (32) | 0.0001 |
| MS IDF | 17% (17) | 28.5% (37) | 42.4% (45) | 49.4% (39) | 0.0001 |
| Criteria: | |||||
| Waist (M ≥ 94, F ≥ 80) | 38% (38) | 55.4% (72) | 73.6% (78) | 70.9% (56) | 0.0001 |
| BP (≥ 130/85) | 43% (43) | 34.6% (45) | 57.5% (61) | 64.7% (51) | 0.0001 |
| HDL (M<40 mg/dl, F<50 mg/dl) | 26% (26) | 27.7% (36) | 31.1% (33) | 31.6% (26) | ns |
| TG (≥ 150 mg/dl) | 33% (33) | 36.1% (47) | 50.9% (54) | 46.8% (37) | 0.0252 |
| Glucose (≥ 100 mg/dl) | 8% (8) | 16.9% (22) | 27.4% (29) | 40.5% (32) | 0.0001 |